e-learning
resources
Vienna 2003
Sunday 28.09.2003
Pharmacological treatment strategies in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy and effectiveness in long-term treatment with different ”new[dcdquote] drug's associations in cold patients
E. Corvaja, F. Andò, G. Girbino, E. Corvaja (Messina, Italy)
Source:
Annual Congress 2003 - Pharmacological treatment strategies in COPD
Session:
Pharmacological treatment strategies in COPD
Session type:
Thematic Poster Session
Number:
447
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Corvaja, F. Andò, G. Girbino, E. Corvaja (Messina, Italy). Efficacy and effectiveness in long-term treatment with different ”new[dcdquote] drug's associations in cold patients. Eur Respir J 2003; 22: Suppl. 45, 447
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 314s
Year: 2006
Does short-term treatment intensification influence long-term treatment effects on health status in COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 293s
Year: 2005
Evaluation of prophylactic observations efficacy and the quality of TB treatment using a math model for primarily revealed patients
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004
Cost consequences of tiotropium plus existing therapy
versus
existing therapy alone following one year of treatment in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001
The influence of the patients‘ participation in trials on the adherence to treatment in future
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012
The effectiveness of different clinical measures in evaluating response to omalizumab
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010
Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Long-term effectiveness of surgery treatment of TB patients
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Efficacy and safety of modified anti-tubercular treatment(ATT) regimens in treatment of tuberculosis(TB) in patients with underlying chronic liver disease(CLD)
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Evaluation of treatment with fixed dose combinations in asthma patients in primary care in Sweden by using mannitol challenge test
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012
Comparison of efficacy and safety of fixed-dose combination regimen versus separate drugs for treatment of tuberculosis
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019
Relationship between prior triple therapy use and benefits of budesonide/glycopyrronium/formoterol on exacerbation risk: analysis from ETHOS
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Year: 2021
A long-term (2 years) efficacy and safety study of doxofylline in the treatment of asthma
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Comparative clinical-functional effectiveness and cardiological safety of short-acting combined broncholytics in 2 months basic therapy in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 74s
Year: 2007
Clinical benefits and safety of long term treatment with montelukast (M) in patients with mild-to-moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001
Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 379s
Year: 2004
Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021
Predicting outcomes and drug resistance with new standardised treatment
Source: Eur Respir J 2011; 37: 974
Year: 2011
One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 618s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept